{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-13",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 2
    }
  },
  "results": [
    {
      "discontinued_date": "08/31/2026",
      "update_type": "New",
      "initial_posting_date": "08/31/2026",
      "package_ndc": "0009-0065-01",
      "generic_name": "Medroxyprogesterone Acetate Tablet",
      "contact_info": "800-533-4535",
      "related_info": "Discontinuation of the manufacture of the drug; Withdrawal from sale expected early October 2026.",
      "openfda": {
        "application_number": [
          "NDA011839"
        ],
        "brand_name": [
          "PROVERA"
        ],
        "generic_name": [
          "MEDROXYPROGESTERONE ACETATE"
        ],
        "manufacturer_name": [
          "Pharmacia & Upjohn Company LLC"
        ],
        "product_ndc": [
          "0009-0065",
          "0009-0287",
          "0009-0051"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "ORAL"
        ],
        "substance_name": [
          "MEDROXYPROGESTERONE ACETATE"
        ],
        "rxcui": [
          "1000114",
          "1000124",
          "1000135",
          "1000139",
          "1000141",
          "1000145"
        ],
        "spl_id": [
          "ebcdf2fb-760c-4a9a-80a1-a0c6b21a891a"
        ],
        "spl_set_id": [
          "a586be28-96af-4fed-a13f-9b94fd4c7405"
        ],
        "package_ndc": [
          "0009-0065-01",
          "0009-0287-01",
          "0009-0051-01"
        ],
        "unii": [
          "C2QI4IOI2G"
        ]
      },
      "update_date": "08/31/2026",
      "therapeutic_category": [
        "Urology"
      ],
      "dosage_form": "Tablet",
      "presentation": "PROVERA, Tablet, 2.5 mg (NDC 0009-0065-01)",
      "company_name": "Pfizer Inc.",
      "status": "To Be Discontinued"
    }
  ]
}